NEUROFIBROMATOSIS 2
Clinical trials for NEUROFIBROMATOSIS 2 explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMATOSIS 2 trials appear
Sign up with your email to follow new studies for NEUROFIBROMATOSIS 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Drug shows promise for rare nerve tumor disorder
Disease control CompletedThis study tested the drug crizotinib in 12 people with neurofibromatosis type 2 (NF2) who had growing tumors on their hearing nerves. The goal was to see if the drug could shrink these tumors. Participants took crizotinib pills daily for up to 12 months. The study is now complet…
Matched conditions: NEUROFIBROMATOSIS 2
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated May 18, 2026 12:10 UTC
-
Video therapy boosts Well-Being in neurofibromatosis patients
Symptom relief CompletedThis study tested two stress and symptom management programs delivered through live video for adults with neurofibromatosis (NF1, NF2, or schwannomatosis). The goal was to see if these programs could improve physical and mental quality of life. 228 participants who reported diffi…
Matched conditions: NEUROFIBROMATOSIS 2
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 11:28 UTC